Galapagos N.V. (GLPG)
NASDAQ·Healthcare·Biotechnology
$27.75
—
Mkt Cap $2.18B
Analyst Ratings
No recent rating data.
Price Target (6 analysts)
$36.50
Range $33.00 – $40.00
Implied Upside
+31.5%
Consensus $36.50 vs current $27.75
NASDAQ·Healthcare·Biotechnology
$27.75
—
Mkt Cap $2.18B
No recent rating data.
Price Target (6 analysts)
$36.50
Range $33.00 – $40.00
+31.5%
Consensus $36.50 vs current $27.75